J Refract Surg. 2000 Mar 2;16(2 Suppl):S257-60. doi: 10.3928/1081-597X-20000302-13.
To conduct an analysis of laser in situ keratomileusis (LASDS) results in patients with artiphakia, after phakic posterior chamber intraocular lens implantation, and after corneal transplantation.
We analyzed the results of 57 eyes with an IOL that had LASDi: 22 eyes- artiphakia after ECCE with IOL implantation; 8 eyes had phacoemulsification with IOL implantation; 9 eyesartiphakia after removal of transparent lens with IOL implantation in patients with the high myopia (ß eyes) and high hyperopia (3 eyes); 3 eyes- phakic posterior chamber IOL (2 with hyperopia, 1 with myopia); and 15 eyes after corneal transplantation. LASDS correction was performed not earlier than 6 months after IOL implantation and not earlier than 18 months after corneal transplantation. Follow-up ranged from 6 to 12 months after LASDS using the Nidek EC-5000 excimer laser. A thorough ophthalmic examination preceded and followed laser correction.
Mean deviation from emmetropia before LASDS was 3.50 D (range, -6.00 to +4.00 D), and astigmatism averaged 2.75 D (range, 0 to 5.00 D). Before LASDS, mean uncorrected visual acuity was 0.2 and mean spectacle-corrected visual acuity was 6 (range, 0.4 to 1.0). After LASDS, mean deviation from emmetropia was 0.50 D (range, -1.50 to +0.75 D) and average astigmatism was -0.75 D (range, 0 to 1.50 D). Mean uncorrected visual acuity was 0.7 (range, 0.4 to 1.0).
LASIK in patients with artiphakia, phakic posterior chamber intraocular lens implantation, and after corneal transplantation was atraumatic, predictable, and efficient. The best results were seen in patients with a myopic refractive error and myopic astigmatism. For hyperopia, LASDS was our method of choice in eyes with "piggy-back" IOLs. J Refract Surg 2000;16(suppl):S257-S260].
分析有晶状体眼后房型人工晶状体植入术后、角膜移植术后和人工晶状体眼激光原位角膜磨镶术(LASIK)的结果。
我们分析了 57 只眼的 LASIK 结果:22 只眼-ECCE 后带人工晶状体植入术后人工晶状体眼;8 只眼-白内障超声乳化后带人工晶状体植入术后人工晶状体眼;9 只眼-高度近视(ß 眼)和高度远视(3 眼)带人工晶状体透明晶状体切除术后人工晶状体眼;3 只眼-后房型有晶状体眼人工晶状体(2 只远视眼,1 只近视眼);15 只眼-角膜移植术后。LASIK 矫正术在人工晶状体植入后 6 个月内和角膜移植后 18 个月内均不进行。使用 Nidek EC-5000 准分子激光,在 LASIK 矫正术后 6 至 12 个月进行随访。在激光矫正术前和术后均进行了全面的眼科检查。
LASIK 术前平均离焦度数为 3.50 D(范围:-6.00 至+4.00 D),平均散光为 2.75 D(范围:0 至 5.00 D)。LASIK 术前平均未矫正视力为 0.2,平均矫正视力为 6(范围:0.4 至 1.0)。LASIK 术后平均离焦度数为 0.50 D(范围:-1.50 至+0.75 D),平均散光为-0.75 D(范围:0 至 1.50 D)。平均未矫正视力为 0.7(范围:0.4 至 1.0)。
有晶状体眼、后房型有晶状体眼人工晶状体植入术后和角膜移植术后的 LASIK 是一种无创伤、可预测和有效的方法。对于近视和近视散光患者,效果最好。对于远视,对于“搭便车”人工晶状体眼,LASIK 是我们的首选方法。《J Refract Surg》2000 年 16 期增刊:S257-S260。